Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-06 · accession 0001415889-25-001142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-08 | 2025-01-06 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | — | +1,250 | 3,676 | +52% | — |
| D | 2025-01-08 | 2025-01-07 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $42.82 | -750 | 2,926 | -20% | -$32.1K |
| D | 2025-01-08 | 2025-01-06 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -1,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-06 | M | A | 1,250 | — | 3,676 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2025-01-07 | S | D | 750 | $42.82 | 2,926 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-01-06 | M | D | 1,250 | $0.00 | 0 | D | — · — to — | 1,250 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023, January 6, 2024 and January 6, 2025. |